KAT6A::CREBBP t(8;16)
Quantitative RT-PCR detection of the KAT6A::CREBBP fusion from t(8;16)(p11;p13) translocation in a subset of AML patients.
Quantitative RT-PCR detection of the KAT6A::CREBBP fusion from t(8;16)(p11;p13) translocation in a subset of AML patients.
PCR fragment-length analysis of duplications/deletions in the CEBPA bZIP domain for AML diagnosis and monitoring.
Quantitative RT-PCR detection of NUP98::NSD1 fusion transcripts from the cryptic t(5;11) translocation.
Sanger sequencing of CXCR4 c-terminal mutations associated with ibrutinib resistance in Waldenström's macroglobulinemia.
Quantitative RT-PCR detection of RUNX1::RUNX1T1 (AML1::ETO) fusion from t(8;21), associated with favorable prognosis in AML.
Quantitative RT-PCR detection of KMT2A::MLLT1 (MLL::ENL) and KMT2A::ELL (MLL::ELL) fusion transcripts from t(11;19) in ALL and AML.
Sanger sequencing of IDH1 exon 4 mutations including R132 to inform IDH inhibitor treatment decisions.
Quantitative RT-PCR detection of KMT2A::MLLT10 fusion transcripts from the t(10;11) translocation.
Quantitative RT-PCR detection of RBM15::MRTFA (MKL1) fusion transcripts from the t(1;22) translocation.
PCR fragment analysis detecting clonal T-cell receptor gamma rearrangements for T-cell malignancy diagnosis and monitoring.


